secwatch.observer — SEC 8-K summary
======================================

Issuer:     AXIM BIOTECHNOLOGIES, INC. (AXIM)
CIK:        0001514946
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001096906-24-002002
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 5.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Change in control at AXIM Biotechnologies; CEO John Huemoeller dies, Catalina Valencia named President
--------------------------------------------------------------------------------

- Kettner Investments acquires control via Series C Preferred Stock transfer from Juniper & Ivy and Medical Marijuana, Inc.
- CEO/President John W. Huemoeller II died Oct 12 due to illness; board appointed Catalina Valencia as President on Oct 9.
- Valencia also appointed Series C Director to fill vacancy from Huemoeller's death; she previously founded Sapphire Biotech.
- Series C stock transferred from Juniper to MJNA to satisfy $515K note, then to Kettner to waive $1.09M notes plus $66K interest.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514946/000109690624002002/0001096906-24-002002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514946/000109690624002002/axim-20241009.htm
  HTML page:      https://secwatch.observer/filing/0001096906-24-002002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer